A Positron Emission Tomography Study Examining The Dopaminergic Activity of Armodafinil in Adults Using [11C]Altropane and [11C]Raclopride
✍ Scribed by Thomas J. Spencer; Bertha K. Madras; Ali A. Bonab; Darin D. Dougherty; Allison Clarke; Tara Mirto; Jessica Martin; Alan J. Fischman
- Book ID
- 119198718
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 555 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0006-3223
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Dexetimide (Fig. la), a potent muscarinic cholinergic receptor antagonist, and levetimide (Fig. lb), its pharmacologically inactive enantiomer, were labeled with "C for non-invasive in vivo studies of muscarinic cholinergic receptors in the human brain using positron emission tomography. The synthes
## Abstract Carbon‐11 labeled __dl‐threo__‐methylphenidate (methyl‐2‐phenyl‐2‐(2‐piperidyl)acetate, Ritalin), a psychostimulant drug widely used to treat attention deficit hyperactivity disorder, was prepared in two steps: O‐methylation of the N‐protected __dl‐threo__‐ritalinic acid derivative with
## Abstract We used [^11^C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D~2~ receptor binding in nine patients with Parkinson's disease (PD) at an early drug‐naive stage and 3–5 years later, when motor fluctuations had appeared in seven of them